Mariner
RDY icon

Mariner’s Dr. Reddy's Laboratories RDY Stock Holding History

Mariner’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Sell
153,818
-67,456
-30% -$910K ﹤0.01% 1427
2026
Q1 		$3.06M Sell
221,274
-11,471
-5% -$160K ﹤0.01% 1281
2025
Q4 		$3.27M Buy
232,745
+49,877
+27% +$700K ﹤0.01% 1218
2025
Q3 		$2.56M Sell
182,868
-10,600
-5% -$153K ﹤0.01% 1282
2025
Q2 		$2.91M Buy
193,468
+59,207
+44% +$845K ﹤0.01% 1114
2025
Q1 		$1.77M Sell
134,261
-4,114
-3% -$56.8K ﹤0.01% 1308
2024
Q4 		$2.18M Buy
138,375
+19,020
+16% +$286K ﹤0.01% 1171
2024
Q3 		$1.9M Buy
119,355
+4,250
+4% +$68.4K ﹤0.01% 1217
2024
Q2 		$1.75M Buy
115,105
+14,760
+15% +$212K ﹤0.01% 1181
2024
Q1 		$1.47M Buy
100,345
+10,540
+12% +$154K ﹤0.01% 1265
2023
Q4 		$1.25M Buy
89,805
+3,030
+3% +$40.5K ﹤0.01% 1291
2023
Q3 		$1.16M Buy
86,775
+2,140
+3% +$29K ﹤0.01% 1242
2023
Q2 		$1.07M Buy
84,635
+8,005
+10% +$93.4K ﹤0.01% 1265
2023
Q1 		$872K Buy
76,630
+8,200
+12% +$88.5K ﹤0.01% 1352
2022
Q4 		$708K Buy
68,430
+27,990
+69% +$302K ﹤0.01% 1428
2022
Q3 		$423K Buy
+40,440
New +$431K ﹤0.01% 1519

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Mariner's RDY Position: Q2 2026 in Review

Mariner reduced its Dr. Reddy's Laboratories (RDY) stake by 30% in Q2 2026, selling an estimated $910K and leaving 153,818 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

Mariner first reported a position in RDY in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.27M in Q4 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Mariner held 153,818 shares of Dr. Reddy's Laboratories worth $2.23M as of Q2 2026.
  • Mariner sold 67,456 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $910K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1427 holding.
  • Mariner first reported a position in Dr. Reddy's Laboratories in Q3 2022 and has held it in 16 quarters since.
  • Mariner's Dr. Reddy's Laboratories position peaked at $3.27M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.